aluates Reports

$ 0.0

Automative

Global Bladder Cancer Targeted Drug Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-37N11570

Global Bladder Cancer Targeted Drug Market Research Report 2022

BUY CHAPTERS

Global Bladder Cancer Targeted Drug Market Research Report 2025

Code: QYRE-Auto-37N11570

Report

January 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Merck KGaA

Roche

Astellas

Janssen Biotech

Bristol–Myers Squibb

Merck

Gilead Sciences

Bladder Cancer Targeted Drug Market Size

The global market for Bladder Cancer Targeted Drug was valued at US$ 903 million in the year 2024 and is projected to reach a revised size of US$ 1658 million by 2031, growing at a CAGR of 9.2% during the forecast period.

Bladder Cancer Targeted Drug Market

Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and tries to limit damage to healthy cells.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bladder Cancer Targeted Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bladder Cancer Targeted Drug.

The Bladder Cancer Targeted Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bladder Cancer Targeted Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bladder Cancer Targeted Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bladder Cancer Targeted Drug Market Report

Report Metric	Details
Report Name	Bladder Cancer Targeted Drug Market
Accounted market size in year	US$ 903 million
Forecasted market size in 2031	US$ 1658 million
CAGR	9.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Atezolizumab (Tecentriq) Avelumab (Bavencio) Erdafitinib (Balversa) Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Merck KGaA, Roche, Astellas, Janssen Biotech, Bristol-Myers Squibb, Merck & Co., Gilead Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bladder Cancer Targeted Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bladder Cancer Targeted Drug Market growing?

Ans: The Bladder Cancer Targeted Drug Market witnessing a CAGR of 9.2% during the forecast period 2025-2031.

What is the Bladder Cancer Targeted Drug Market size in 2031?

Ans: The Bladder Cancer Targeted Drug Market size in 2031 will be US$ 1658 million.

Who are the main players in the Bladder Cancer Targeted Drug Market report?

Ans: The main players in the Bladder Cancer Targeted Drug Market are Pfizer, Merck KGaA, Roche, Astellas, Janssen Biotech, Bristol-Myers Squibb, Merck & Co., Gilead Sciences

What are the Application segmentation covered in the Bladder Cancer Targeted Drug Market report?

Ans: The Applications covered in the Bladder Cancer Targeted Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Bladder Cancer Targeted Drug Market report?

Ans: The Types covered in the Bladder Cancer Targeted Drug Market report are Atezolizumab (Tecentriq), Avelumab (Bavencio), Erdafitinib (Balversa), Other

Recommended Reports

Bladder & Urological Cancer

Targeted Cancer Therapies

Cancer Drugs & Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bladder Cancer Targeted Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Atezolizumab (Tecentriq)

1.2.3 Avelumab (Bavencio)

1.2.4 Erdafitinib (Balversa)

1.2.5 Other

1.3 Market by Application

1.3.1 Global Bladder Cancer Targeted Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bladder Cancer Targeted Drug Market Perspective (2020-2031)

2.2 Global Bladder Cancer Targeted Drug Growth Trends by Region

2.2.1 Global Bladder Cancer Targeted Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bladder Cancer Targeted Drug Historic Market Size by Region (2020-2025)

2.2.3 Bladder Cancer Targeted Drug Forecasted Market Size by Region (2026-2031)

2.3 Bladder Cancer Targeted Drug Market Dynamics

2.3.1 Bladder Cancer Targeted Drug Industry Trends

2.3.2 Bladder Cancer Targeted Drug Market Drivers

2.3.3 Bladder Cancer Targeted Drug Market Challenges

2.3.4 Bladder Cancer Targeted Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bladder Cancer Targeted Drug Players by Revenue

3.1.1 Global Top Bladder Cancer Targeted Drug Players by Revenue (2020-2025)

3.1.2 Global Bladder Cancer Targeted Drug Revenue Market Share by Players (2020-2025)

3.2 Global Bladder Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bladder Cancer Targeted Drug Revenue

3.4 Global Bladder Cancer Targeted Drug Market Concentration Ratio

3.4.1 Global Bladder Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Targeted Drug Revenue in 2024

3.5 Global Key Players of Bladder Cancer Targeted Drug Head office and Area Served

3.6 Global Key Players of Bladder Cancer Targeted Drug, Product and Application

3.7 Global Key Players of Bladder Cancer Targeted Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bladder Cancer Targeted Drug Breakdown Data by Type

4.1 Global Bladder Cancer Targeted Drug Historic Market Size by Type (2020-2025)

4.2 Global Bladder Cancer Targeted Drug Forecasted Market Size by Type (2026-2031)

5 Bladder Cancer Targeted Drug Breakdown Data by Application

5.1 Global Bladder Cancer Targeted Drug Historic Market Size by Application (2020-2025)

5.2 Global Bladder Cancer Targeted Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bladder Cancer Targeted Drug Market Size (2020-2031)

6.2 North America Bladder Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bladder Cancer Targeted Drug Market Size by Country (2020-2025)

6.4 North America Bladder Cancer Targeted Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bladder Cancer Targeted Drug Market Size (2020-2031)

7.2 Europe Bladder Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bladder Cancer Targeted Drug Market Size by Country (2020-2025)

7.4 Europe Bladder Cancer Targeted Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bladder Cancer Targeted Drug Market Size (2020-2031)

8.2 Asia-Pacific Bladder Cancer Targeted Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bladder Cancer Targeted Drug Market Size (2020-2031)

9.2 Latin America Bladder Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bladder Cancer Targeted Drug Market Size by Country (2020-2025)

9.4 Latin America Bladder Cancer Targeted Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bladder Cancer Targeted Drug Market Size (2020-2031)

10.2 Middle East & Africa Bladder Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Bladder Cancer Targeted Drug Introduction

11.1.4 Pfizer Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Bladder Cancer Targeted Drug Introduction

11.2.4 Merck KGaA Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.2.5 Merck KGaA Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Bladder Cancer Targeted Drug Introduction

11.3.4 Roche Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Astellas

11.4.1 Astellas Company Details

11.4.2 Astellas Business Overview

11.4.3 Astellas Bladder Cancer Targeted Drug Introduction

11.4.4 Astellas Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.4.5 Astellas Recent Development

11.5 Janssen Biotech

11.5.1 Janssen Biotech Company Details

11.5.2 Janssen Biotech Business Overview

11.5.3 Janssen Biotech Bladder Cancer Targeted Drug Introduction

11.5.4 Janssen Biotech Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.5.5 Janssen Biotech Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Bladder Cancer Targeted Drug Introduction

11.6.4 Bristol-Myers Squibb Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Merck & Co.

11.7.1 Merck & Co. Company Details

11.7.2 Merck & Co. Business Overview

11.7.3 Merck & Co. Bladder Cancer Targeted Drug Introduction

11.7.4 Merck & Co. Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.7.5 Merck & Co. Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Bladder Cancer Targeted Drug Introduction

11.8.4 Gilead Sciences Revenue in Bladder Cancer Targeted Drug Business (2020-2025)

11.8.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Merck KGaA

Roche

Astellas

Janssen Biotech

Bristol–Myers Squibb

Merck

Gilead Sciences

List of Tables

Table 1. Global Bladder Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Atezolizumab (Tecentriq)

Table 3. Key Players of Avelumab (Bavencio)

Table 4. Key Players of Erdafitinib (Balversa)

Table 5. Key Players of Other

Table 6. Global Bladder Cancer Targeted Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Bladder Cancer Targeted Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Bladder Cancer Targeted Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Bladder Cancer Targeted Drug Market Share by Region (2020-2025)

Table 10. Global Bladder Cancer Targeted Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Bladder Cancer Targeted Drug Market Share by Region (2026-2031)

Table 12. Bladder Cancer Targeted Drug Market Trends

Table 13. Bladder Cancer Targeted Drug Market Drivers

Table 14. Bladder Cancer Targeted Drug Market Challenges

Table 15. Bladder Cancer Targeted Drug Market Restraints

Table 16. Global Bladder Cancer Targeted Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Bladder Cancer Targeted Drug Market Share by Players (2020-2025)

Table 18. Global Top Bladder Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer Targeted Drug as of 2024)

Table 19. Ranking of Global Top Bladder Cancer Targeted Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Bladder Cancer Targeted Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Bladder Cancer Targeted Drug, Headquarters and Area Served

Table 22. Global Key Players of Bladder Cancer Targeted Drug, Product and Application

Table 23. Global Key Players of Bladder Cancer Targeted Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Bladder Cancer Targeted Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Bladder Cancer Targeted Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Bladder Cancer Targeted Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Bladder Cancer Targeted Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Bladder Cancer Targeted Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Bladder Cancer Targeted Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Bladder Cancer Targeted Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Bladder Cancer Targeted Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Bladder Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Bladder Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Bladder Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Bladder Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Bladder Cancer Targeted Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Bladder Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bladder Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Bladder Cancer Targeted Drug Product

Table 51. Pfizer Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Merck KGaA Company Details

Table 54. Merck KGaA Business Overview

Table 55. Merck KGaA Bladder Cancer Targeted Drug Product

Table 56. Merck KGaA Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 57. Merck KGaA Recent Development

Table 58. Roche Company Details

Table 59. Roche Business Overview

Table 60. Roche Bladder Cancer Targeted Drug Product

Table 61. Roche Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 62. Roche Recent Development

Table 63. Astellas Company Details

Table 64. Astellas Business Overview

Table 65. Astellas Bladder Cancer Targeted Drug Product

Table 66. Astellas Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 67. Astellas Recent Development

Table 68. Janssen Biotech Company Details

Table 69. Janssen Biotech Business Overview

Table 70. Janssen Biotech Bladder Cancer Targeted Drug Product

Table 71. Janssen Biotech Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 72. Janssen Biotech Recent Development

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Bladder Cancer Targeted Drug Product

Table 76. Bristol-Myers Squibb Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Merck & Co. Company Details

Table 79. Merck & Co. Business Overview

Table 80. Merck & Co. Bladder Cancer Targeted Drug Product

Table 81. Merck & Co. Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 82. Merck & Co. Recent Development

Table 83. Gilead Sciences Company Details

Table 84. Gilead Sciences Business Overview

Table 85. Gilead Sciences Bladder Cancer Targeted Drug Product

Table 86. Gilead Sciences Revenue in Bladder Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 87. Gilead Sciences Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Bladder Cancer Targeted Drug Picture

Figure 2. Global Bladder Cancer Targeted Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bladder Cancer Targeted Drug Market Share by Type: 2024 VS 2031

Figure 4. Atezolizumab (Tecentriq) Features

Figure 5. Avelumab (Bavencio) Features

Figure 6. Erdafitinib (Balversa) Features

Figure 7. Other Features

Figure 8. Global Bladder Cancer Targeted Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Bladder Cancer Targeted Drug Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Bladder Cancer Targeted Drug Report Years Considered

Figure 14. Global Bladder Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Bladder Cancer Targeted Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Bladder Cancer Targeted Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Bladder Cancer Targeted Drug Market Share by Players in 2024

Figure 18. Global Top Bladder Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer Targeted Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Bladder Cancer Targeted Drug Revenue in 2024

Figure 20. North America Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Bladder Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 22. United States Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Bladder Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 26. Germany Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Bladder Cancer Targeted Drug Market Share by Region (2020-2031)

Figure 34. China Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Bladder Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 42. Mexico Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Bladder Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 46. Turkey Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Bladder Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 50. Merck KGaA Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 52. Astellas Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 53. Janssen Biotech Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 55. Merck & Co. Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 56. Gilead Sciences Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Targeted Drug Market Research Report 2025

Global Cancer Targeted Small Molecule Therapy Market Research Report 2025

Global Bladder Cancer Therapeutics and Diagnostics Market Research Report 2024

Global Targeted Small Molecule Drug Market Research Report 2025

Global Targeted Small Molecule Therapy Market Research Report 2025

Global Targeted Cancer Therapy Market Research Report 2024

Global Oncology Targeted Therapy Market Research Report 2025

Global Targeted Oncology Drugs Market Research Report 2024

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Bladder Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bladder Cancer Clinical Trials Market

Global Injectable Targeted Therapy Market Research Report 2024

Global Breast Cancer Targeted Drug Market Research Report 2025

Global Targeted Radiotherapy Drug Market Research Report 2024

Global Targeted Antitumor Drugs Market Research Report 2025

Global Muscle Invasive Bladder Cancer Treatment Market Research Report 2024

Global Targeted Therapy for Brain Cancer Market Research Report 2025

Global Personalized Cancer Medicine Market Research Report 2025

Global Targeted Chemotherapy Drugs Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions